X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
87
PharmaCompass offers a list of Cyproheptadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cyproheptadine Hydrochloride API Price utilized in the formulation of products. Cyproheptadine Hydrochloride API Price is not always fixed or binding as the Cyproheptadine Hydrochloride Price is obtained through a variety of data sources. The Cyproheptadine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyproheptadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyproheptadine, including repackagers and relabelers. The FDA regulates Cyproheptadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyproheptadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyproheptadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyproheptadine supplier is an individual or a company that provides Cyproheptadine active pharmaceutical ingredient (API) or Cyproheptadine finished formulations upon request. The Cyproheptadine suppliers may include Cyproheptadine API manufacturers, exporters, distributors and traders.
click here to find a list of Cyproheptadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cyproheptadine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cyproheptadine active pharmaceutical ingredient (API) in detail. Different forms of Cyproheptadine DMFs exist exist since differing nations have different regulations, such as Cyproheptadine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cyproheptadine DMF submitted to regulatory agencies in the US is known as a USDMF. Cyproheptadine USDMF includes data on Cyproheptadine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cyproheptadine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cyproheptadine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cyproheptadine Drug Master File in Japan (Cyproheptadine JDMF) empowers Cyproheptadine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cyproheptadine JDMF during the approval evaluation for pharmaceutical products. At the time of Cyproheptadine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cyproheptadine suppliers with JDMF on PharmaCompass.
A Cyproheptadine CEP of the European Pharmacopoeia monograph is often referred to as a Cyproheptadine Certificate of Suitability (COS). The purpose of a Cyproheptadine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cyproheptadine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cyproheptadine to their clients by showing that a Cyproheptadine CEP has been issued for it. The manufacturer submits a Cyproheptadine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cyproheptadine CEP holder for the record. Additionally, the data presented in the Cyproheptadine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cyproheptadine DMF.
A Cyproheptadine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cyproheptadine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cyproheptadine suppliers with CEP (COS) on PharmaCompass.
A Cyproheptadine written confirmation (Cyproheptadine WC) is an official document issued by a regulatory agency to a Cyproheptadine manufacturer, verifying that the manufacturing facility of a Cyproheptadine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cyproheptadine APIs or Cyproheptadine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cyproheptadine WC (written confirmation) as part of the regulatory process.
click here to find a list of Cyproheptadine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyproheptadine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyproheptadine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyproheptadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyproheptadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyproheptadine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyproheptadine suppliers with NDC on PharmaCompass.
Cyproheptadine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyproheptadine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyproheptadine GMP manufacturer or Cyproheptadine GMP API supplier for your needs.
A Cyproheptadine CoA (Certificate of Analysis) is a formal document that attests to Cyproheptadine's compliance with Cyproheptadine specifications and serves as a tool for batch-level quality control.
Cyproheptadine CoA mostly includes findings from lab analyses of a specific batch. For each Cyproheptadine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyproheptadine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyproheptadine EP), Cyproheptadine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyproheptadine USP).
Market Place
